Esophageal Cancer
Polo-like kinase and survivin are esophageal tumor-specific promoters
Published in Gene Therapy Weekly, May 11th, 2006
"For developing successful cancer gene therapy strategies, tumor-specific gene delivery is essential. In this study, we used esophageal cancer (EC) cells to identify and evaluate esophageal tumor-specific gene promoters," wrote F. Sato and colleagues, University of Maryland.
"Four genes (polo-like kinase-1/PLK, survivin/BIRC5, karyopherin alpha 2/KPNA2, and pituitary tumor transforming gene protein 1/PTTG1) were identified by a microarray analysis as highly expressed in EC cell lines vs. five normal organ tissues (liver, lung,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-05-11)
More Articles from Gene Therapy Weekly
- Antisense Technology
Antisense oligodeoxynucleotides can be delivered from cationically modified polymer films - Antisense Technology
Morpholino antisense oligonucleotides inhibit Oct4 expression - Cancer Gene Therapy
Breast cancer cell invasiveness is affected by matrix metalloproteinase - Gene Therapy
Calcitonin gene-related peptide receptor is activated by gene transfer - Gene Transfer
Gene transfer and enzyme replacement eliminates abnormal fibroblast sialylglycoproteins - Alveolar Cancer
Bronchoalveolar cell carcinoma is reduced by gene-modified dendritic cells - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
